[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Wendy B. London<\/i><\/u><\/presenter>. Dana-Farber Cancer Institute\/Boston Children's Hospital, Boston, MA","CSlideId":"","ControlKey":"0f32004a-e9a1-4203-a90d-998ba501ae5f","ControlNumber":"9638","DisclosureBlock":"&nbsp;<b>&nbsp;W.B. London:<\/b>  ; Healthcast. ; Jubliant Draximage, Inc.. ; Merck. ; Y-mabs Therapeutics.","End":"4\/6\/2024 10:01:00 AM","HasWebcast":null,"Highlights":[],"Id":"2998","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Wendy London, PhD","PresenterKey":"965774f1-a506-4a15-a5e5-bf970f3c56fd","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr  6 2024 10:00AM","SessionId":"497","SessionOnDemand":"False","SessionTitle":"Biostatistics in Clinical Trials Workshop: Out of the Rut and Beyond the Traditional, Part 2 - Designing Pivotal Phase 3 Trials for Regulatory Approval of New Agents or New Indications ","ShowChatLink":"false","Start":"4\/6\/2024 10:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Wendy B. London<\/i><\/u><\/presenter>. Dana-Farber Cancer Institute\/Boston Children's Hospital, Boston, MA","CSlideId":"","ControlKey":"30f287a3-43a2-4a18-8962-5023d034db77","ControlNumber":"9640","DisclosureBlock":"<b>&nbsp;W. B. London, <\/b> <br><b>Healthcast<\/b> I. <br><b>Jubliant Draximage, Inc.<\/b> I. <br><b>Merck<\/b> I. <br><b>Y-mabs Therapeutics<\/b> I.","End":"4\/6\/2024 10:02:00 AM","HasWebcast":null,"Highlights":[],"Id":"3000","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Wendy London, PhD","PresenterKey":"965774f1-a506-4a15-a5e5-bf970f3c56fd","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Introduction","SearchResultFooter":"","SearchResultHeader":"Apr  6 2024 10:00AM","SessionId":"497","SessionOnDemand":"False","SessionTitle":"Biostatistics in Clinical Trials Workshop: Out of the Rut and Beyond the Traditional, Part 2 - Designing Pivotal Phase 3 Trials for Regulatory Approval of New Agents or New Indications ","ShowChatLink":"false","Start":"4\/6\/2024 10:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Introduction","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Frank Bretz<\/i><\/u><\/presenter>. Novartiz Pharma AG, Basel, Switzerland","CSlideId":"","ControlKey":"529e59d6-72bf-4757-a583-26b47ecd949f","ControlNumber":"11063","DisclosureBlock":"","End":"4\/6\/2024 10:22:00 AM","HasWebcast":null,"Highlights":[],"Id":"9626","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Frank Bretz","PresenterKey":"5073e987-8e7a-438c-b1aa-d016fcf4ad52","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Multiplicity considerations in cancer research","SearchResultFooter":"","SearchResultHeader":"Apr  6 2024 10:00AM","SessionId":"497","SessionOnDemand":"False","SessionTitle":"Biostatistics in Clinical Trials Workshop: Out of the Rut and Beyond the Traditional, Part 2 - Designing Pivotal Phase 3 Trials for Regulatory Approval of New Agents or New Indications ","ShowChatLink":"false","Start":"4\/6\/2024 10:02:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Multiplicity considerations in cancer research","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>John Peipert<\/i><\/u><\/presenter>. Northwestern University Feinberg School of Medicine, Chicago, IL","CSlideId":"","ControlKey":"2ce96409-3ff3-4eaa-ac60-184a25cffe00","ControlNumber":"11241","DisclosureBlock":"","End":"4\/6\/2024 10:42:00 AM","HasWebcast":null,"Highlights":[],"Id":"9865","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"John Peipert","PresenterKey":"baa272f5-5914-49af-9b4c-9699c3973582","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Improved use of PROs as endpoints in clinical trials","SearchResultFooter":"","SearchResultHeader":"Apr  6 2024 10:00AM","SessionId":"497","SessionOnDemand":"False","SessionTitle":"Biostatistics in Clinical Trials Workshop: Out of the Rut and Beyond the Traditional, Part 2 - Designing Pivotal Phase 3 Trials for Regulatory Approval of New Agents or New Indications ","ShowChatLink":"false","Start":"4\/6\/2024 10:22:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Improved use of PROs as endpoints in clinical trials","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Mary W. Redman<\/i><\/u><\/presenter>. Fred Hutchinson Cancer Research Ctr., Seattle, WA","CSlideId":"","ControlKey":"9be5a93b-fc8b-4ad1-ae77-f27d080d0422","ControlNumber":"11060","DisclosureBlock":"","End":"4\/6\/2024 11:02:00 AM","HasWebcast":null,"Highlights":[],"Id":"9623","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Mary Redman, PhD","PresenterKey":"c5af9222-b70f-48c7-9afb-95862ffd8793","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Biomarker-driven designs","SearchResultFooter":"","SearchResultHeader":"Apr  6 2024 10:00AM","SessionId":"497","SessionOnDemand":"False","SessionTitle":"Biostatistics in Clinical Trials Workshop: Out of the Rut and Beyond the Traditional, Part 2 - Designing Pivotal Phase 3 Trials for Regulatory Approval of New Agents or New Indications ","ShowChatLink":"false","Start":"4\/6\/2024 10:42:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Biomarker-driven designs","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Susan Halabi<\/i><\/u><\/presenter>. Duke University, Durham, NC","CSlideId":"","ControlKey":"27bcf6f6-a6a8-4106-849c-8ad6b3a408c5","ControlNumber":"11061","DisclosureBlock":"","End":"4\/6\/2024 11:17:00 AM","HasWebcast":null,"Highlights":[],"Id":"9624","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Susan Halabi, PhD","PresenterKey":"b24d4b22-9927-4fdf-88bc-58b86fc57d9c","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Biomarker-driven designs","SearchResultFooter":"","SearchResultHeader":"Apr  6 2024 10:00AM","SessionId":"497","SessionOnDemand":"False","SessionTitle":"Biostatistics in Clinical Trials Workshop: Out of the Rut and Beyond the Traditional, Part 2 - Designing Pivotal Phase 3 Trials for Regulatory Approval of New Agents or New Indications ","ShowChatLink":"false","Start":"4\/6\/2024 11:02:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Biomarker-driven designs","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"74e1e73e-553b-4135-9f5b-939d49f29abf","ControlNumber":"11386","DisclosureBlock":"","End":"4\/6\/2024 11:30:00 AM","HasWebcast":null,"Highlights":[],"Id":"10033","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Panel discussion","SearchResultFooter":"","SearchResultHeader":"Apr  6 2024 10:00AM","SessionId":"497","SessionOnDemand":"False","SessionTitle":"Biostatistics in Clinical Trials Workshop: Out of the Rut and Beyond the Traditional, Part 2 - Designing Pivotal Phase 3 Trials for Regulatory Approval of New Agents or New Indications ","ShowChatLink":"false","Start":"4\/6\/2024 11:17:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Panel discussion","Topics":null,"cSlideId":""}]